Derma Sciences, Inc. (DSCI) Reports Second Quarter Financial Results
8/12/2013 6:57:54 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June 30, 2013. Highlights of the second quarter of 2013 and recent weeks include:
•Advanced wound care (AWC) product sales of $7.9 million, up 36% over the prior-year second quarter
Help employers find you! Check out all the jobs and post your resume.